跳至主要内容
临床试验/IRCT20130719014054N2
IRCT20130719014054N2招募中3 期

The investigation of the efficacy and safety of Empagliflozin in the treatment of heart failure in people who living with HIV/AIDS: Randomized, Clinical Trial study

Tehran University of Medical Sciences0 个研究点目标入组 128 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
128

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Age >18YEARS

排除标准

  • MALIGNANCY OR Opportunistic infection
  • CKD AND GFR<20

研究者

相似试验

尚未招募
2 期
Exploratory survey of the safety and efficacy of endoscopic radiofrequency ablation for malignant biliary strictureMalignant biliary stricture
JPRN-UMIN000031601Graduate School of Medicine, Chiba University10
进行中(未招募)
1 期
A Study to Evaluate the Efficacy and Safety of Ezetimibe/Simvastatin and Fenofibrate Coadministration in Patients With Mixed Hyperlipidemia - Ezetimibe/Simvastatin and Fenofibrate Coadministration StudyMixed hyperlipidemia
EUCTR2004-003807-19-ESMerck & Co Inc.600
进行中(未招募)
不适用
A Study to Evaluate the Efficacy and Safety of Ezetimibe/Simvastatin and Fenofibrate Coadministration in Patients With Mixed Hyperlipidemia - Ezetimibe/Simvastatin and Fenofibrate Coadministration StudyMixed hyperlipidemiaMedDRA version: 7.0Level: LLTClassification code 10027762
EUCTR2004-003807-19-ATMerck, Sharp & Dohme600
进行中(未招募)
1 期
A Study to Evaluate the Efficacy and Safety of Ezetimibe/Simvastatin and Fenofibrate Coadministration in Patients With Mixed Hyperlipidemia - Ezetimibe/Simvastatin and Fenofibrate Coadministration StudyMedDRA version: 7.0 Level: LLT Classification code 10027762Mixed hyperlipidemia
EUCTR2004-003807-19-GBMerck Sharp & Dohme Ltd600
进行中(未招募)
不适用
A Study to Evaluate the Efficacy and Safety of Ezetimibe/Simvastatin and Fenofibrate Coadministration in Patients With Mixed Hyperlipidemia - Ezetimibe/Simvastatin and Fenofibrate Coadministration StudyMedDRA version: 7.0Level: LLTClassification code 10027762Mixed hyperlipidemia
EUCTR2004-003807-19-HUMerck & Co., Inc.600